Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01745835
Other study ID # Coolprep study
Secondary ID
Status Completed
Phase Phase 3
First received November 27, 2012
Last updated March 7, 2018
Start date January 30, 2013
Est. completion date January 31, 2014

Study information

Verified date February 2017
Source Seoul National University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

comparison of the use of Colyte® (ascorbic acid mixed polyethylene glycol solution) in two-liter versus one-liter volume and pretreatment with bisacodyl for colonoscopy preparation.


Recruitment information / eligibility

Status Completed
Enrollment 196
Est. completion date January 31, 2014
Est. primary completion date August 31, 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 75 Years
Eligibility Inclusion Criteria:

- willing to consent/undergo necessary procedures

- between the age of 20 and 75 years

- healthy persons planning to have a colonoscopy

Exclusion Criteria:

- history of abdominal surgery except appendectomy

- inflammatory bowel disease

- clinically or laboratory-confirmed ileus (both functional and mechanical)

- malignancy

- clinically severe cerebrovascular, cardiovascular, kidney, liver or hematologic disease

- dementia, cognitive impairment

- the use of prokinetics, antispasmodics, antidiarrheal drugs, laxatives or neuroleptics in 2 weeks

- known sensitivity to the agents used

- Pregnancy, Lactating woman

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
2L Coolprep®
* Compositions/1L : Sodium Chloride 2.691g Potassium Chloride 1.015g Anhydrous sodium sulfate 7.5g PEG 3350 100g ascorbic acid 4.7g sodium ascorbate 5.9g
1L Coolprep® and Bisacodyl
Coolprep® (TaeJoon Pharmaceuticals, Seoul, Korea) * Compositions/1L : Sodium Chloride 2.691g Potassium Chloride 1.015g Anhydrous sodium sulfate 7.5g PEG 3350 100g ascorbic acid 4.7g sodium ascorbate 5.9g Dulcolax-S® (Boehringer Ingelheim ,Seoul, Korea) * composition /1 tablet : Bisacodyl 5mg, docusate sodium 16.75mg

Locations

Country Name City State
Korea, Republic of Seoul National University Hospital Seoul City

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Other Patient's compliance using questionnaires on the day of the colonoscopy
Other Patient's acceptance using questionnare on the day of the colonoscopy
Other Patient's satisfaction using questionnaires on the day of the colonoscopy
Primary Bowel cleansing scale using SNUH scale on the day of the colonoscopy
Secondary Bowel cleansing scale of Right/Transverse/Left colon also using SNUH scale on the day of the colonoscopy
See also
  Status Clinical Trial Phase
Recruiting NCT06432738 - ZL-82 Double-blind Clinical Trial Phase 1
Recruiting NCT05693233 - Effect of Soft Robotic Exosuit Assistance in Healthy People N/A
Terminated NCT03775473 - PROgastrine COlon DEpistage N/A
Recruiting NCT06387966 - A Randomized, Double-blind,Dose-escalating, Single-dose, Oral Phase I Clinical Study of Flunotinib Healthy People Phase 1
Completed NCT05316857 - DDI Study of Orelabrutinib Phase 1
Completed NCT06213792 - Visuo-Vestibular Adaptation in Virtual Reality